PubMed:21676868
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-112 | Sentence | denotes | Unfolded protein response is required in nu/nu mice microvasculature for treating breast tumor with tunicamycin. |
| T2 | 113-240 | Sentence | denotes | Up-regulation of the dolichol pathway, a "hallmark" of asparagine-linked protein glycosylation, enhances angiogenesis in vitro. |
| T3 | 241-328 | Sentence | denotes | The dynamic relationship between these two processes is now evaluated with tunicamycin. |
| T4 | 329-455 | Sentence | denotes | Capillary endothelial cells treated with tunicamycin were growth inhibited and could not be reversed with exogenous VEGF(165). |
| T5 | 456-670 | Sentence | denotes | Inhibition of angiogenesis is supported by down-regulation of (i) phosphorylated VEGFR1 and VEGFR2 receptors; (ii) VEGF(165)-specific phosphotyrosine kinase activity; and (iii) Matrigel(TM) invasion and chemotaxis. |
| T6 | 671-781 | Sentence | denotes | In vivo, tunicamycin prevented the vessel development in Matrigel(TM) implants in athymic Balb/c (nu/nu) mice. |
| T7 | 782-887 | Sentence | denotes | Immunohistochemical analysis of CD34 (p < 0.001) and CD144 (p < 0.001) exhibited reduced vascularization. |
| T8 | 888-1071 | Sentence | denotes | A 3.8-fold increased expression of TSP-1, an endogenous angiogenesis inhibitor in Matrigel(TM) implants correlated with that in tunicamycin (32 h)-treated capillary endothelial cells. |
| T9 | 1072-1247 | Sentence | denotes | Intravenous injection of tunicamycin (0.5 mg/kg to 1.0 mg/kg) per week slowed down a double negative (MDA-MB-435) grade III breast adenocarcinoma growth by ∼50-60% in 3 weeks. |
| T10 | 1248-1398 | Sentence | denotes | Histopathological analysis of the paraffin sections indicated significant reduction in vessel size, the microvascular density and tumor mitotic index. |
| T11 | 1399-1459 | Sentence | denotes | Ki-67 and VEGF expression in tumor tissue were also reduced. |
| T12 | 1460-1546 | Sentence | denotes | A significant reduction of N-glycan expression in tumor microvessel was also observed. |
| T13 | 1547-1969 | Sentence | denotes | High expression of GRP-78 in CD144-positive cells supported unfolded protein response-mediated ER stress in tumor microvasculature. ∼65% reduction of a triple negative (MDA-MB-231) breast tumor xenograft in 1 week with tunicamycin (0.25 mg/kg) given orally and the absence of systemic and/or organ failure strongly supported tunicamycin's potential for a powerful glycotherapeutic treatment of breast cancer in the clinic. |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 706-712 | http://purl.obolibrary.org/obo/MAT_0000393 | denotes | vessel |
| T2 | 1335-1341 | http://purl.obolibrary.org/obo/MAT_0000393 | denotes | vessel |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1378-1383 | HP_0002664 | denotes | tumor |
| T2 | 1428-1433 | HP_0002664 | denotes | tumor |
| T3 | 1510-1515 | HP_0002664 | denotes | tumor |
| T4 | 1655-1660 | HP_0002664 | denotes | tumor |
| T5 | 1728-1740 | HP_0003002 | denotes | breast tumor |
| T6 | 1728-1740 | HP_0100013 | denotes | breast tumor |
| T7 | 1735-1740 | HP_0002664 | denotes | tumor |
| T8 | 1941-1954 | HP_0003002 | denotes | breast cancer |
| T9 | 1941-1954 | HP_0100013 | denotes | breast cancer |
| T10 | 1948-1954 | HP_0002664 | denotes | cancer |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 82-94 | Disease | denotes | breast tumor | http://purl.obolibrary.org/obo/MONDO_0007254|http://purl.obolibrary.org/obo/MONDO_0021100 |
| T3 | 923-926 | Disease | denotes | TSP | http://purl.obolibrary.org/obo/MONDO_0008039 |
| T4 | 1196-1217 | Disease | denotes | breast adenocarcinoma | http://purl.obolibrary.org/obo/MONDO_0004988 |
| T5 | 1378-1383 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T6 | 1428-1433 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T7 | 1510-1515 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T8 | 1655-1660 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T9 | 1728-1740 | Disease | denotes | breast tumor | http://purl.obolibrary.org/obo/MONDO_0007254|http://purl.obolibrary.org/obo/MONDO_0021100 |
| T11 | 1941-1954 | Disease | denotes | breast cancer | http://purl.obolibrary.org/obo/MONDO_0007254 |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 706-712 | Body_part | denotes | vessel | http://purl.obolibrary.org/obo/MAT_0000393 |
| T2 | 1335-1341 | Body_part | denotes | vessel | http://purl.obolibrary.org/obo/MAT_0000393 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 82-94 | Phenotype | denotes | breast tumor | HP:0100013 |
| T2 | 1378-1383 | Phenotype | denotes | tumor | HP:0002664 |
| T3 | 1428-1433 | Phenotype | denotes | tumor | HP:0002664 |
| T4 | 1510-1515 | Phenotype | denotes | tumor | HP:0002664 |
| T5 | 1655-1660 | Phenotype | denotes | tumor | HP:0002664 |
| T6 | 1728-1740 | Phenotype | denotes | breast tumor | HP:0100013 |
| T7 | 1941-1954 | Phenotype | denotes | breast cancer | HP:0003002 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 47-51 | OrganismTaxon | denotes | mice | 10088 |
| T2 | 776-780 | OrganismTaxon | denotes | mice | 10088 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 52-68 | Body_part | denotes | microvasculature | http://purl.obolibrary.org/obo/UBERON_8410081 |
| T2 | 82-88 | Body_part | denotes | breast | http://purl.obolibrary.org/obo/UBERON_0000310 |
| T3 | 329-356 | Body_part | denotes | Capillary endothelial cells | http://purl.obolibrary.org/obo/CL_0002144 |
| T4 | 706-712 | Body_part | denotes | vessel | http://purl.obolibrary.org/obo/UBERON_0000055 |
| T5 | 1043-1070 | Body_part | denotes | capillary endothelial cells | http://purl.obolibrary.org/obo/CL_0002144 |
| T6 | 1196-1202 | Body_part | denotes | breast | http://purl.obolibrary.org/obo/UBERON_0000310 |
| T7 | 1335-1341 | Body_part | denotes | vessel | http://purl.obolibrary.org/obo/UBERON_0000055 |
| T8 | 1434-1440 | Body_part | denotes | tissue | http://purl.obolibrary.org/obo/UBERON_0000479 |
| T9 | 1516-1527 | Body_part | denotes | microvessel | http://purl.obolibrary.org/obo/UBERON_8410081 |
| T10 | 1661-1677 | Body_part | denotes | microvasculature | http://purl.obolibrary.org/obo/UBERON_8410081 |
| T11 | 1728-1734 | Body_part | denotes | breast | http://purl.obolibrary.org/obo/UBERON_0000310 |
| T12 | 1839-1844 | Body_part | denotes | organ | http://purl.obolibrary.org/obo/UBERON_0000062|http://purl.obolibrary.org/obo/UBERON_0003103 |
| T14 | 1941-1947 | Body_part | denotes | breast | http://purl.obolibrary.org/obo/UBERON_0000310 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 329-356 | Cell | denotes | Capillary endothelial cells | http://purl.obolibrary.org/obo/CL:0002144 |
| T2 | 1043-1070 | Cell | denotes | capillary endothelial cells | http://purl.obolibrary.org/obo/CL:0002144 |